12-(Lys)4-12

General Information


DRACP ID  DRACP00983

Peptide Name   12-(Lys)4-12

Sequence  KKKK

Sequence Length  4

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 0% Killing=32µM; 15% Killing=64µM; 95% Killing=128µM Not available Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00983

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  C12

C-terminal Modification  C12

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C24H50N8O5

Absent amino acids  ACDEFGHILMNPQRSTVWY

Common amino acids  K

Mass  58440

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  0

Net charge  4

Boman Index  -2220

Hydrophobicity  -390

Aliphatic Index  0

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32193931

Title  Gemini Peptide Amphiphiles with Broad-Spectrum Antimicrobial Activity and Potent Antibiofilm Capacity

Doi 10.1021/acsami.0c01167

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.